Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm -2019/20 group results

May 21 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           60.43           61.83                                
               (-2.3 pct)      (-4.2 pct)                              
  Operating        4.09            3.74                                
               (+9.6 pct)      (-22.6 pct)                             
  Recurring        3.88            3.30                                
               (+17.7 pct)     (-35.2 pct)                             
  Net
  Net              2.93            3.45                                
               (-15.3 pct)     (-16.9 pct)                             
  EPS           62.62 yen       69.56 yen                              
  Ann Div       34.00 yen       34.00 yen      34.00 yen               
  -Q2 Div       17.00 yen       17.00 yen      17.00 yen               
  -Q4 Div       17.00 yen       17.00 yen      17.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T

Recent news on Zeria Pharmaceutical

See all news